Skip to main content

KalVista Pharmaceuticals, Inc.

KALVDelisted Jun 11, 2026
Industry
Pharmaceutical Preparations
SEC CIK
0001348911

KalVista Pharmaceuticals, Inc. was delisted on Jun 11, 2026; its insiders filed their last Form 4 on Jun 11, 2026; 184 institutions reported holding it in 13F filings for Q1 2026, worth $1.39B in total; no superinvestor held it.

Q1 2022 vs. Q4 2021

How the institutions holding KalVista Pharmaceuticals, Inc. changed between Q4 2021 and Q1 2022.

All holders in Q1 2022All holders in Q4 2021

13F holders of KALV: Q4 2021 compared with Q1 2022
MeasureQ4 2021Q1 2022Change
Holders9789−8
Shares23.8M24.3M+549.6K (+2.3%)
Value$314.6M$363.9M+$49.2M (+15.6%)

New holders (11)

Institutions that held KalVista Pharmaceuticals, Inc. at the end of Q1 2022 but not at the end of Q4 2021.

Institutions new to KALV in Q1 2022
InstitutionSharesValue% of portfolio
Frazier Life Sciences Management, L.P.1,572,192$23.2M1.97%
Tang Capital Management LLC648,269$9.55M1.93%
Walleye Capital LLC64,210$946.0K0.03%
Marshall Wace, LLP36,359$536.0K0.00%
Millennium Management LLC17,148$253.0K0.00%
Amalgamated Bank3,652$54.0K0.00%
Amalgamated Financial Corp.3,652$54.0K0.00%
Lindbrook Capital, LLC112$2.00K0.00%
Simplex Trading, LLC66$00.00%
CWM, LLC11$00.00%
Ellevest, Inc.19$00.00%

Sold out (19)

Institutions that held KalVista Pharmaceuticals, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.